- 関
- activated-leukocyte cell adhesion molecule
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/02/24 08:45:00」(JST)
[Wiki en表示]
Activated leukocyte cell adhesion molecule |
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1KJC
|
|
|
Identifiers |
Symbols |
ALCAM ; CD166; MEMD |
External IDs |
OMIM: 601662 MGI: 1313266 HomoloGene: 1229 GeneCards: ALCAM Gene |
Gene ontology |
Molecular function |
• receptor binding
• protein binding
|
Cellular component |
• focal adhesion
• external side of plasma membrane
• integral component of membrane
• axon
• neuronal cell body
• extracellular exosome
|
Biological process |
• cell adhesion
• signal transduction
• axon guidance
• motor neuron axon guidance
|
Sources: Amigo / QuickGO |
|
Orthologs |
Species |
Human |
Mouse |
Entrez |
214 |
11658 |
Ensembl |
ENSG00000170017 |
ENSMUSG00000022636 |
UniProt |
Q13740 |
Q61490 |
RefSeq (mRNA) |
NM_001243280 |
NM_009655 |
RefSeq (protein) |
NP_001230209 |
NP_033785 |
Location (UCSC) |
Chr 3:
105.37 – 105.58 Mb |
Chr 16:
52.25 – 52.45 Mb |
PubMed search |
[1] |
[2] |
|
CD166 antigen is a 100-105 kD typeI transmembrane glycoprotein that is a member of the immunoglobulin superfamily of proteins. In humans it is encoded by the ALCAM gene.[1][2] It is also called CD166 (cluster of differentiation 166), MEMD, SC-1/DM-GRASP/BEN in the chicken, and KG-CAM in the rat. Some literature sources have also cited it as the CD6 ligand (CD6L). It is expressed on activated T cells, activated monocytes, epithelial cells, fibroblasts, neurons, melanoma cells, and also in sweat and sebaceous glands. CD166 protein expression is reported to be upregulated in a cell line deriving from a metastasizing melanoma. CD166 plays an important role in mediating adhesion interactions between thymic epithelial cells and CD6+ cells during intrathymic T cell development. Recently, CD166 has also been used as a potential cancer stem cell marker.
References
- ^ Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U; et al. (Jun 1995). "Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand". J Exp Med 181 (6): 2213–20. doi:10.1084/jem.181.6.2213. PMC 2192054. PMID 7760007.
- ^ "Entrez Gene: ALCAM activated leukocyte cell adhesion molecule".
Further reading
- Whitney GS, Starling GC, Bowen MA; et al. (1995). "The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.". J. Biol. Chem. 270 (31): 18187–90. doi:10.1074/jbc.270.31.18187. PMID 7543097.
- Bajorath J, Bowen MA, Aruffo A (1996). "Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.". Protein Sci. 4 (8): 1644–7. doi:10.1002/pro.5560040822. PMC 2143187. PMID 8520490.
- Skonier JE, Bowen MA, Emswiler J; et al. (1996). "Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.". Biochemistry 35 (38): 12287–91. doi:10.1021/bi961038k. PMID 8823162.
- Singer NG, Mitra R, Lialios F; et al. (1998). "CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.". Immunol. Lett. 58 (1): 9–14. doi:10.1016/S0165-2478(97)02707-7. PMID 9436462.
- Degen WG, van Kempen LC, Gijzen EG; et al. (1998). "MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).". Am. J. Pathol. 152 (3): 805–13. PMC 1858405. PMID 9502422.
- Cortés F, Deschaseaux F, Uchida N; et al. (1999). "HCA, an immunoglobulin-like adhesion molecule present on the earliest human hematopoietic precursor cells, is also expressed by stromal cells in blood-forming tissues.". Blood 93 (3): 826–37. PMID 9920831.
- Tomita K, van Bokhoven A, Jansen CF; et al. (2000). "Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.". Biochem. Biophys. Res. Commun. 267 (3): 870–4. doi:10.1006/bbrc.1999.2040. PMID 10673383.
- van Kempen LC, Nelissen JM, Degen WG; et al. (2001). "Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.". J. Biol. Chem. 276 (28): 25783–90. doi:10.1074/jbc.M011272200. PMID 11306570.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Kristiansen G, Pilarsky C, Wissmann C; et al. (2003). "ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.". Prostate 54 (1): 34–43. doi:10.1002/pros.10161. PMID 12481253.
- Zhang H, Li XJ, Martin DB, Aebersold R (2003). "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.". Nat. Biotechnol. 21 (6): 660–6. doi:10.1038/nbt827. PMID 12754519.
- Fujiwara H, Tatsumi K, Kosaka K; et al. (2003). "Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166).". J. Clin. Endocrinol. Metab. 88 (7): 3437–43. doi:10.1210/jc.2002-021888. PMID 12843199.
- Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- van Kempen LC, Meier F, Egeblad M; et al. (2004). "Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.". J. Invest. Dermatol. 122 (5): 1293–301. doi:10.1111/j.0022-202X.2004.22531.x. PMID 15140234.
- Zimmerman AW, Nelissen JM, van Emst-de Vries SE; et al. (2005). "Cytoskeletal restraints regulate homotypic ALCAM-mediated adhesion through PKCalpha independently of Rho-like GTPases.". J. Cell. Sci. 117 (Pt 13): 2841–52. doi:10.1242/jcs.01139. PMID 15169840.
- Ikeda K, Quertermous T (2005). "Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.". J. Biol. Chem. 279 (53): 55315–23. doi:10.1074/jbc.M407776200. PMID 15496415.
- Verma A, Shukla NK, Deo SV; et al. (2005). "MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma.". Oncology 68 (4–6): 462–70. doi:10.1159/000086989. PMID 16024937.
- Lunter PC, van Kilsdonk JW, van Beek H; et al. (2005). "Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity". Cancer Res. 65 (19): 8801–8. doi:10.1158/0008-5472.CAN-05-0378. PMID 16204050.
- Liu T, Qian WJ, Gritsenko MA; et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMC 1850943. PMID 16335952.
External links
- ALCAM at the US National Library of Medicine Medical Subject Headings (MeSH)
Protein: scleroproteins
|
|
Extracellular matrix |
Collagen |
Fibril forming |
- type I
- type II (COL2A1)
- type III
- type V
- COL24A1
- COL26A1
|
|
Other |
- FACIT: type IX
- type XII (COL12A1)
- COL14A1
- COL16A1
- COL19A1
- COL20A1
- COL21A1
- COL22A1
- basement membrane: type IV
- COL4A1
- COL4A2
- COL4A3
- COL4A4
- COL4A5
- COL4A6
- multiplexin: COL15A1
- type XVIII
- transmembrane: COL13A1
- COL17A1
- COL23A1
- COL25A1
- other: type VI
- COL6A1
- COL6A2
- COL6A3
- COL6A5
- type VII (COL7A1)
- type VIII
- type X (COL10A1)
- type XI
- COL27A1
- COL28A1
|
|
Enzymes |
- Prolyl hydroxylase/Lysyl hydroxylase
- Cartilage associated protein/Leprecan
- ADAMTS2
- Procollagen peptidase
- Lysyl oxidase
|
|
|
Laminin |
- alpha
- LAMA1
- LAMA2
- LAMA3
- LAMA4
- LAMA5
- beta
- gamma
|
|
Other |
- ALCAM
- Elastin
- Vitronectin
- FRAS1
- FREM2
- Decorin
- FAM20C
- ECM1
- Matrix gla protein
- Tectorin
|
|
|
Other |
- Keratin/Cytokeratin
- Gelatin
- Reticulin
- Cartilage oligomeric matrix protein
|
|
English Journal
- miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
- Song Q1, Xu Y, Yang C, Chen Z, Jia C, Chen J, Zhang Y, Lai P, Fan X, Zhou X, Lin J, Li M, Ma W, Luo S, Bai X.Author information 1Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University.AbstractThe nodal regulatory properties of microRNAs in metastatic cancer may offer new targets for therapeutic control. Here we report that upregulation of miR-483-5p is correlated with the progression of human lung adenocarcinoma. miR-483-5p promotes epithelial-mesenchymal transition (EMT) accompanied by invasive and metastatic properties of lung adenocarcinoma. Mechanistically, miR-483-5p is activated by the WNT/β-catenin signaling pathway and exerts its pro-metastatic function by directly targeting the Rho GDP dissociation inhibitor alpha (RhoGDI1) and activated leukocyte cell adhesion molecule (ALCAM), two putative metastasis suppressors. What's more, we found that downregulation of RhoGDI1 enhances expression of Snail thereby promoting EMT. Importantly, miR-483-5p levels are positively correlated with β-catenin expression, but are negatively correlated with the levels of RhoGDI1 and ALCAM in human lung adenocarcinoma. Our findings reveal that miR-483-5p is a critical β-catenin-activated pro-metastatic microRNA and a negative regulator of the metastasis suppressors RhoGDI1 and ALCAM.
- Cancer research.Cancer Res.2014 Apr 7. [Epub ahead of print]
- The nodal regulatory properties of microRNAs in metastatic cancer may offer new targets for therapeutic control. Here we report that upregulation of miR-483-5p is correlated with the progression of human lung adenocarcinoma. miR-483-5p promotes epithelial-mesenchymal transition (EMT) accompanied by
- PMID 24710410
- Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6.
- Te Riet J1, Helenius J, Strohmeyer N, Cambi A, Figdor CG, Müller DJ.Author information 1Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 28, 6525 GA Nijmegen, The Netherlands.AbstractAt the immunological synapse, the activated leukocyte cell adhesion molecule (ALCAM) on a dendritic cell (DC) and CD6 molecules on a T cell contribute to sustained DC-T-cell contacts. However, little is known about how ALCAM-CD6 bonds resist and adapt to mechanical stress. Here, we combine single-cell force spectroscopy (SCFS) with total-internal reflection fluorescence microscopy to examine ALCAM-CD6-mediated cell adhesion. The combination of cells expressing ALCAM constructs with certain cytoplasmic tail mutations and improved SCFS analysis processes reveal that the affinity of ALCAM-CD6 bonds is not influenced by the linking of the intracellular domains of ALCAM to the actin cortex. By contrast, the recruitment of ALCAM to adhesion sites and the propensity of ALCAM to anchor plasma membrane tethers depend on actin cytoskeletal interactions. Furthermore, linking ALCAM to the actin cortex through adaptor proteins stiffens the cortex and strengthens cell adhesion. We propose a framework for how ALCAMs contribute to DC-T-cell adhesion, stabilize DC-T-cell contacts and form a mechanical link between CD6 and the actin cortex to strengthen cell adhesion at the immunological synapse.
- Journal of cell science.J Cell Sci.2014 Apr 1;127(Pt 7):1595-606. doi: 10.1242/jcs.141077. Epub 2014 Feb 4.
- At the immunological synapse, the activated leukocyte cell adhesion molecule (ALCAM) on a dendritic cell (DC) and CD6 molecules on a T cell contribute to sustained DC-T-cell contacts. However, little is known about how ALCAM-CD6 bonds resist and adapt to mechanical stress. Here, we combine single-ce
- PMID 24496453
- Functional role of endothelial adhesion molecules in the early stages of brain metastasis.
- Soto MS1, Serres S, Anthony DC, Sibson NR.Author information 1CR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford, UK (M.S.S., S. S., N.R.S.; Department of Pharmacology, University of Oxford, Oxford UK (D.C.A.).AbstractBACKGROUND: Cellular adhesion molecules (CAMs), which are normally associated with leukocyte trafficking, have also been shown to play an essential role in tumor metastasis to non-CNS sites. However, the role played by CAMs in brain metastasis is largely unexplored. It is known that leukocyte recruitment to the brain is very atypical and that mechanisms of disease in peripheral tissues cannot be extrapolated to the brain. Here, we have established the spatiotemporal expression of 12 key CAMs in the initial phases of tumor seeding in 2 different models of brain metastasis.
- Neuro-oncology.Neuro Oncol.2014 Apr;16(4):540-51. doi: 10.1093/neuonc/not222. Epub 2013 Dec 4.
- BACKGROUND: Cellular adhesion molecules (CAMs), which are normally associated with leukocyte trafficking, have also been shown to play an essential role in tumor metastasis to non-CNS sites. However, the role played by CAMs in brain metastasis is largely unexplored. It is known that leukocyte recrui
- PMID 24311639
Japanese Journal
- Hematopoietic stem cells and niche cell populations
- 9-24.ヒト胚および子宮内膜上皮におけるactivated leukocyte cell adhesion molecule(ALCAM/CD166)の発現(第40群 生殖生理・病理5)(一般演題)
- 胚との相互作用における着床期子宮内膜の機能変化とその分子機構の解析(子宮内膜機能の調節機構 : 着床機構の視点から)
Related Links
- CD166抗原は、Activaed leukocyte cell adhesion molecule(ALCAM)として知られているⅠ型膜貫通タンパクです。10箇所のN結合型糖鎖附加部位を含む、免疫グロブリンスーパーファミリー分子です。分子量100-105kDaで、5個の細胞外Ig様 ...
- SC Alcam International este o companie tanara care-si propune sa fie foarte receptive la tendintele pietei si cerintele clientilor. Cu o puternica orientare catre client si cerintele acestuia compania isi propune sa creeze pe piata ...
- Catégories Vidéosurveillance Gamme Vidéo "Essentiels" Gamme Vidéo "Pro" Enregistreurs Alarmes Alarme GSM Accessoires Alarme Nos services Garantie AlCam Support technique SAV A propos Qui sommes-nous ? C.G.V
Related Pictures
★リンクテーブル★
[★]
- 英
- activated-leukocyte cell adhesion molecule、ALCAM
[★]
活性化白血球細胞接着分子
- 関
- ALCAM